The SHS portfolio company TNI medical is receiving further funding in a second financing round. Two new investors – the Portuguese investment firm Pathena and a private investor – are investing in the Würzburg based company. The existing investors, SHS Gesellschaft für Beteiligungsmanagement and KfW, will be retaining shares. TNI medical is a leading provider of innovative treatment methods for patients with chronic obstructive pulmonary disease (COPD) and respiratory complaints.
